Marijuana Stocks

Much like the U.S. legal status on marijuana, the verdict on marijuana stocks is still up in the air. While the bulls like to think that the marijuana industry is about to explode with their optimism over the pending decriminalization and legalization of marijuana, the bears view marijuana stocks as a very risky investment to the point that they may be scams. Marijuana Penny Stocks such as Cannabis Science Inc (CBIS) are risky due to fact that they are in a grey legal area. But as Canada’s nascent legal marijuana market blossoms, many pot stocks are worth adding to your portfolio.

Related to Marijuana Stocks:

We’ve Reached the Must-Hold Support Point for Aurora Cannabis Stock

By Bret Kenwell, InvestorPlace Contributor
Aurora Cannabis has been decimated. It has a potentially tradable bottom, but there's not much to love about ACB stock now.

Aurora Cannabis Stock Needs Some Christmas Magic

By Dana Blankenhorn, InvestorPlace Contributor
So far, pot smokers don't want to give their money to the legal side of the business. For investors, that means ACB stock is a name to avoid.

Canopy Growth Stock Can Climb, But How Much Is Debatable

By Todd Shriber, InvestorPlace Contributor
Canopy Growth stock has been caught up in the slump affecting all marijuana stocks, but CGC appears sturdier than its rivals.

Two Key Reasons Not to Buy the Dip in Canopy Growth Stock

By Vince Martin, InvestorPlace Contributor
Near the lows, CGC stock might look tempting. But investors should keep two troublesome factors in mind when it comes to Canopy Growth stock.

Don’t Count on Altria to Keep the Price of Cronos Stock Propped Up

By Mark R. Hake, CFA
Cronos stock is severely overvalued and is likely to fall further. Cronos is more expensive than any other Canadian cannabis stock, even despite the recent Altria investment

Aurora Cannabis Stock Still Offers Long-Term Growth Opportunity

By Ian Cooper, InvestorPlace Contributor
The downgrades and the pullback in ACB stock have led to overkill. The stock is now obscenely oversold at double-bottom support.

Has Aurora Cannabis Stock Finally Bottomed Out?

By Brad Moon, InvestorPlace Contributor
With the Canadian recreational cannabis market finally gaining some steam, is ACB stock poised to recover from its seven-month slump?

4 Key Players Just Held a Marijuana Summit

By InvestorPlace Research Staff
The governors of four important U.S. states just got together to discuss marijuana legalization. Now's the time to get in cannabis stocks!

Friday’s Vital Data: Intel, Tesla and Cronos Group

By Tyler Craig, Tales of a Technician
Options trading was hot in Intel, Tesla and Cronos Group stocks on Thursday. Here’s what the data suggests moving forward.

Aphria Stock Looks Like the Best Cannabis Play Right Now

By Vince Martin, InvestorPlace Contributor
Aphria stock, like other cannabis stocks, has plunged. But while risks remain, APHA stock looks attractive here.

Canopy Growth Stock Is the Best Card in a Bad Hand of Cannabis Stocks

By Dana Blankenhorn, InvestorPlace Contributor
CGC has the cash to wait for marijuana's full legalization, thanks to majority owner Constellation Brands.

Black Market Weed Hurts Struggling Canopy Growth Stock

By Ian Bezek, InvestorPlace Contributor
Some investors have focused on Canopy's lawsuit with Go Farm Hemp. But there's a much bigger issue plaguing CGC stock at the moment.

Lift a Glass to Legal Cannabis’ Next Big Trend — and Opportunity

By InvestorPlace Research Staff
Legalization 2.0 in Canada will soon start to show us what cannabis products consumers like, and which ones will be weeded out (pun intended).

Aurora Cannabis Stock Is Still Not Worth a Buy

By Chris Tyler, InvestorPlace Contributor
If history repeats itself, ACB stock could lead the bulls to big-time profits. But there’s still plenty of work to be done before Aurora Cannabis is buy-worthy.

Marijuana REIT Innovative Industrial Properties Grows With LivWell Deal

By Louis Navellier, Editor, Growth Investor
IIPR stock has a foothold in one of the fastest-growing industries -- marijuana. If you can stomach some volatility, IIPR is a smart choice.

Investors Should Jump Into Cronos Group Stock’s Mystery Moves

By David Moadel, InvestorPlace Contributor
CRON stock is not for the faint of heart. Do you think you have what it takes to profit from this pot powerhouse?

Shareholders Worry as Tilray Stock Approaches IPO Price

By Mark Putrino, CMT
If Tilray stock breaks the $17 level, the IPO price will become a resistance level. Investors should also expect short selling there.

Investors Beware: Tilray Stock Might Not Be Done Dropping

By Will Healy, InvestorPlace Contributor
Tilray stock probably has further to fall since TLRY must overcome further funding obstacles before it can become a profitable company.

Where Is the Rebound for Fallen Canopy Growth Stock?

By Chris Lau, InvestorPlace Contributor
What are investors worried about ahead of the upcoming CGC earnings report? For many, it's the expectation of near-term losses.
Load More